521 related articles for article (PubMed ID: 33552062)
1. Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still's Disease: Similarities and Differences.
Meng J; Ma Y; Jia J; Wang M; Teng J; Shi H; Liu H; Su Y; Ye J; Sun Y; Cheng X; Chi H; Liu T; Zhu D; Zhou Z; Wan L; Wang Z; Wang F; Qiao X; Chen X; Zhang H; Tang Z; Yang C; Hu Q
Front Immunol; 2020; 11():603389. PubMed ID: 33552062
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-18 Is a Potential Biomarker to Discriminate Active Adult-Onset Still's Disease From COVID-19.
Chen PK; Lan JL; Huang PH; Hsu JL; Chang CK; Tien N; Lin HJ; Chen DY
Front Immunol; 2021; 12():719544. PubMed ID: 34367188
[TBL] [Abstract][Full Text] [Related]
3. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease.
Chen DY; Lan JL; Lin FJ; Hsieh TY
J Rheumatol; 2004 Nov; 31(11):2189-98. PubMed ID: 15517632
[TBL] [Abstract][Full Text] [Related]
4. Current and emerging biological therapy in adult-onset Still's disease.
Ma Y; Meng J; Jia J; Wang M; Teng J; Zhu D; Yang C; Hu Q
Rheumatology (Oxford); 2021 Sep; 60(9):3986-4000. PubMed ID: 34117886
[TBL] [Abstract][Full Text] [Related]
5. Adult-onset Still's disease.
Gerfaud-Valentin M; Jamilloux Y; Iwaz J; Sève P
Autoimmun Rev; 2014 Jul; 13(7):708-22. PubMed ID: 24657513
[TBL] [Abstract][Full Text] [Related]
6. Serum sTREM-1 in adult-onset Still's disease: a novel biomarker of disease activity and a potential predictor of the chronic course.
Wang Z; Chi H; Sun Y; Teng J; Feng T; Liu H; Cheng X; Ye J; Shi H; Hu Q; Jia J; Liu T; Wan L; Zhou Z; Qiao X; Yang C; Su Y
Rheumatology (Oxford); 2020 Nov; 59(11):3293-3302. PubMed ID: 32276274
[TBL] [Abstract][Full Text] [Related]
7. Elevated serum gasdermin D N-terminal implicates monocyte and macrophage pyroptosis in adult-onset Still's disease.
Nagai H; Kirino Y; Nakano H; Kunishita Y; Henmi R; Szymanski AM; Yoshimi R; Ombrello MJ; Nakajima H
Rheumatology (Oxford); 2021 Aug; 60(8):3888-3895. PubMed ID: 33550379
[TBL] [Abstract][Full Text] [Related]
8. Adult onset Still's disease (AOSD) in the era of biologic therapies: dichotomous view for cytokine and clinical expressions.
Maria AT; Le Quellec A; Jorgensen C; Touitou I; Rivière S; Guilpain P
Autoimmun Rev; 2014 Nov; 13(11):1149-59. PubMed ID: 25183244
[TBL] [Abstract][Full Text] [Related]
9. Elevated serum levels of interleukin-10 in adult-onset Still's disease are associated with disease activity.
Sun Y; Wang Z; Chi H; Hu Q; Ye J; Liu H; Cheng X; Shi H; Zhou Z; Teng J; Yang C; Su Y
Clin Rheumatol; 2019 Nov; 38(11):3205-3210. PubMed ID: 31236746
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive review on adult onset Still's disease.
Giacomelli R; Ruscitti P; Shoenfeld Y
J Autoimmun; 2018 Sep; 93():24-36. PubMed ID: 30077425
[TBL] [Abstract][Full Text] [Related]
11. Serum cytokine profiles in patients with adult onset Still's disease.
Choi JH; Suh CH; Lee YM; Suh YJ; Lee SK; Kim SS; Nahm DH; Park HS
J Rheumatol; 2003 Nov; 30(11):2422-7. PubMed ID: 14677188
[TBL] [Abstract][Full Text] [Related]
12. Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature.
Kötter I; Wacker A; Koch S; Henes J; Richter C; Engel A; Günaydin I; Kanz L
Semin Arthritis Rheum; 2007 Dec; 37(3):189-97. PubMed ID: 17583775
[TBL] [Abstract][Full Text] [Related]
13. Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis.
Hu Q; Gong W; Gu J; Geng G; Li T; Tian R; Yang Z; Zhang H; Shao L; Liu T; Wan L; Jia J; Yang C; Shi Y; Shi H
Front Immunol; 2018; 9():3099. PubMed ID: 30687316
[TBL] [Abstract][Full Text] [Related]
14. Serum Mac-2 binding protein glycosylation isomer and galectin-3 levels in adult-onset Still's disease and their association with cytokines.
Yoshida S; Koga T; Fujita Y; Yatsuhashi H; Matsumoto H; Sumichika Y; Saito K; Sato S; Asano T; Kobayakawa M; Ohira H; Mizokami M; Sugiyama M; Migita K
Front Immunol; 2024; 15():1385654. PubMed ID: 38711500
[TBL] [Abstract][Full Text] [Related]
15. Circulating regulatory T cells in adult-onset Still's disease: Focusing on their plasticity and stability.
Shimojima Y; Ichikawa T; Kishida D; Takamatsu R; Sekijima Y
Clin Exp Immunol; 2021 Nov; 206(2):184-195. PubMed ID: 34319596
[TBL] [Abstract][Full Text] [Related]
16. Biomarker screening and validation for the differentiation of bloodstream infection from adult-onset Still's disease: A prospective cohort study.
Zhang W; Yang T; Zhang H; Xu Y; Yang Q; Liu Q; Gao Y; Wu J; Shao L; Zhang W
Cytokine; 2021 Oct; 146():155642. PubMed ID: 34325118
[TBL] [Abstract][Full Text] [Related]
17. Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still's disease.
Chen DY; Lan JL; Lin FJ; Hsieh TY; Wen MC
Ann Rheum Dis; 2004 Oct; 63(10):1300-6. PubMed ID: 15361391
[TBL] [Abstract][Full Text] [Related]
18. sCD163 in AOSD: a biomarker for macrophage activation related to hyperferritinemia.
Colafrancesco S; Priori R; Alessandri C; Astorri E; Perricone C; Blank M; Agmon-Levin N; Shoenfeld Y; Valesini G
Immunol Res; 2014 Dec; 60(2-3):177-83. PubMed ID: 25388964
[TBL] [Abstract][Full Text] [Related]
19. [Current concepts on the physiopathology of adult-onset Still's disease].
Arlet JB; Le Thi Huong DB; Pouchot J; Piette JC
Rev Med Interne; 2005 Jul; 26(7):549-56. PubMed ID: 15996569
[TBL] [Abstract][Full Text] [Related]
20. TLR4 Endogenous Ligand S100A8/A9 Levels in Adult-Onset Still's Disease and Their Association with Disease Activity and Clinical Manifestations.
Kim HA; Han JH; Kim WJ; Noh HJ; An JM; Yim H; Jung JY; Kim YS; Suh CH
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27537874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
